CoChat

Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer

Open access
Chen, Bihong T., Jin, Taihao, Patel, Sunita K., Ye, Ningrong, Sun, Can-Lan, Ma, Huiyan, Rockne, Russell C., Root, James C., Saykin, Andrew J., Ahles, Tim A., Holodny, Andrei I., Prakash, Neal, Mortimer, Joanne, Waisman, James, Yuan, Yuan, Li, Daneng, Somlo, George, Vazquez, Jessica, Levi, Abrahm, Tan, Heidi, Yang, Richard, Katheria, Vani, Hurria, Arti · 2018 · Breast Cancer Research and Treatment
Cited by 44

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Purpose: The purpose of this study was to evaluate longitudinal changes in brain gray matter density (GMD) before and after adjuvant chemotherapy in older women with breast cancer. Methods: We recruited 16 women aged ≥ 60 years with stage I–III breast cancers receiving adjuvant chemotherapy (CT) and 15 age- and sex-matched healthy controls (HC). The CT group underwent brain MRI and the NIH Toolbox for Cognition testing prior to adjuvant chemotherapy (time point 1, TP1) and within 1 month after chemotherapy (time point 2, TP2). The HC group underwent the same assessments at matched intervals. GMD was evaluated with the voxel-based morphometry. Results: The mean age was 67 years in the CT group and 68.5 years in the HC group. There was significant GMD reduction within the chemotherapy group from TP1 to TP2. Compared to the HC group, the CT group displayed statistically significantly greater GMD reductions from TP1 to TP2 in the brain regions involving the left anterior cingulate gyrus, right insula, and left middle temporal gyrus (pFWE(family-wise error)-corrected < 0.05). The baseline GMD in left insula was positively correlated with the baseline list-sorting working memory score in the HC group (pFWE-corrected < 0.05). No correlation was observed for the changes in GMD with the changes in cognitive testing scores from TP1 to TP2 (pFWE-corrected < 0.05). Conclusions: Our findings indicate that GMD reductions were associated with adjuvant chemotherapy in older women with breast cancer. Future studies are needed to understand the clinical significance of the neuroimaging findings. This study is registered on ClinicalTrials.gov (NCT01992432).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10549-018-4911-y

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 44

Metadata

Authors
Chen, B. T., Jin, T., Patel, S. K., Ye, N., Sun, C.-L., Ma, H., Rockne, R. C., Root, J. C., Saykin, A. J., Ahles, T. A., Holodny, A. I., Prakash, N., Mortimer, J., Waisman, J., Yuan, Y., Li, D., Somlo, G., Vazquez, J., Levi, A., Tan, H., Yang, R., Katheria, V., & Hurria, A.
Venue
Breast Cancer Research and Treatment
Published
2018-08-07
Volume
172
Issue
2
Pages
363-370
ISSN
  • 0167-6806 (ISSN-L)
  • 1573-7217
OpenAlex
W2885255578
Cited by
44
References
1
FWCI
2.71
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer. https://app.cochat.ai/papers/10.1007/s10549-018-4911-y
The paper
Chen, B. T., Jin, T., Patel, S. K., Ye, N., Sun, C.-L., Ma, H., Rockne, R. C., Root, J. C., Saykin, A. J., Ahles, T. A., Holodny, A. I., Prakash, N., Mortimer, J., Waisman, J., Yuan, Y., Li, D., Somlo, G., Vazquez, J., Levi, A., . . . Hurria, A. (2018). Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-018-4911-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.